Corange Signs Back-to-Back, Big Money Biotech Deals...Again
Executive Summary
Corange shocked the industry in 1993 with its two blockbuster $200+ million late stage alliances with CellPro and Protein Design Labs. Corange was then run by Max Link--let go after both employee revolutions and board disagreement with his high-risk biotech vision. Now Corange has signed two early stage collaborations that could bring over $150 million in total to biotechs GeneMedicine and Sequana Therapeutics. But the structures are far more conservative than those done under Link.